FDA Approved: PROTONIX DELAYED-RELEASE — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved the original application for Pantoprazole sodium delayed-release (Protonix Delayed-Release) by Wyeth/Pfizer for the treatment of gastroesophageal r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• PROTONIX DELAYED-RELEASE (Pantoprazole sodium)

Snippet

ORIG AP for PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM)